known in relation to digestive pathology. We herein report two cases with severe digestive pathology suggestive of Chagas' disease, in which circulating T. cruzi DNA was demonstrated by PCR.
CASE REPORTS

Case 1.
A 65-year-old man living in the province of Esmeraldas (northwestern area of Ecuador) but born in an area highly endemic for Chagas (province of Loja, southwestern region), sought medical assistance due to chronic constipation. His chief complaint was abdominal pain and no bowel movements for the last two weeks. Physical examination revealed abdominal distension and tenderness. Rectal examination revealed the presence of a fecaloma. Hematological and biochemical blood tests were all within normal limits. Radiological studies of the abdomen confir med the presence of a large amount of fecal material in the rectosigmoidal region along with pronounced achalasia of esophagus. ( Figure  1A ). Oesophago-gastroduodenoscopy revealed the presence of esophagectasis, while a colonoscopy showed dolichomegacolon. Histopathological studies on biopsies taken from the esophagus and colon showed neuronal lesions in the esophageal and intestinal mesenteric plexuses. A diagnosis of dolichomegaesophagus and megacolon was made. Figure 1B) . On hospital admission, the patient was dyspneic due to abdominal distension. An emergency laparotomy was done which revealed an extremely dilated colon, in particular the sigmoid, occupying the whole abdominal cavity. A fecaloma was found in the rectum. A sigmoidectomy and colostomy was performed. Histopathological studies on the tissues showed ganglionar cells with d e g e n e r a t i v e c h a n g e s . A d i a g n o s i s o f dolichomegacolon was made.
Diagnosis of T. cruzi Infection. Serology. Since the histopathological studies showed nonspecific changes, and since megaviscera can be associated with Chagas' disease, sera from both patients were tested for anti-T. cruzi antibodies. ELISA tests were performed using as antigens an epimastigote crude extract and a recombinant T. cruzi specific antigen (rTc24) 8 . A strong positive reaction against both antigens was seen with sera from both patients.
DNA preparation and Tc24-based polymerase chain reaction. Antibodies against rTc24 reflect the presence of an active T. cruzi infection or an unsuccessful treatment 9 , while those directed against crude lysate indicate exposure to the parasite. To confirm the possible existence of a T. cruzi infection, a PCR assay 6 was performed as follows: 5ml of venous blood from both patients were collected with EDTA. 200µl of each sample were brought up to 400µl with PCR grade water and mixed with the same volume of 2X lysis buffer (20mM EDTA, 20mM
Tris-HCl, 300mM NaCl, 0.4% SDS). Proteinase K (final concentration 100µg/ml) was added and the tubes were incubated for one hour at 56 o C. Samples were then extracted once with phenol/chloroform/isoamyl alcohol (25:21:4) and once with pure chloroform followed by ethanol DNA precipitation. As a negative control blood sample serologically negative for T. cruzi from a endemic area was used, while a pGEX-2T plasmid containing the Tc24 cDNA was used as the positive control. For PCR assay, 5µl of purified DNA templates were added in a final volume of 50-µl reaction containing 100 pmol of Tc24-specific primers: T1 5´ GACGGCAAGAACGCCAAGGAC 3´ and T2 5´ TCACGCGCTCTCCGGCACGTTGTC 3´, and 2.5 units of Taq 
DISCUSSION
This report definitively demonstrated the presence of digestive pathology associated with Chagas' disease in Ecuador. The positive PCR results confirmed that the parasite T. cruzi was still present in both patients. In Latin America, there is evidence suggesting geographic differences in the prevalence of megaviscera in Chagas' disease 7 . In chagasic endemic regions in Brazil, Argentina and Chile, the prevalence of megaviscera is high, while in the Andean South and Central American countries megaviscera are absent or very rare. Digestive pathology with probable chagasic etiology has been reported in Mexico while in Venezuela only changes in esophageal motility has been shown in T. cruzi infected patients 12 . The cases we report here emphazise that digestive pathology associated with T. cruzi infection may not be as rare as previously thought.
It is of interest that the patients in this study came from different geographical endemic regions in Ecuador; Morona Santiago province located in the eastern side of the Andes and Loja province located on the western side. Recently, additional cases from other provinces, Pastaza and El Oro have been documented (R. Guderian, unpublished observations) supporting the notion that digestive pathology due to American trypanosomiasis may be underestimated in Ecuador.
Antiparasitic treatment of chronic cases with severe pathology is still controversial. Surgical intervention is recommended in chagasic patients with complicated megaviscera 10 . In the two cases described in this report, both patients showed complications such as fecaloma. Surgery was done in case 2 with a satisfactory result. In case 1, clinical treatment was sufficient to improve esophageal function.
Control strategies for Chagas' disease currently rely on reduction of transmission by insecticide spraying. However, asymptomatic chronic cases constitute a potential risk of transfusionassociated transmission of T. cruzi and reactivation of the disease in immunodepressed T. cruzi infected individuals. Thus, in co-infections with HIV, the classical clinical manifestations of the disease may become altered, as neurological disturbances such as meningoencephalitis have been observed 13 . More detailed surveys to determine seropositivity, quality of blood products and their derivatives used for transfusion, and consequent pathology due to Chagas' disease are still required in Ecuador to define the epidemiology of this disease. 
RESUMO
